Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Orthostatic hypotension? 46 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Orthostatic hypotension have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.

46
Reports of Orthostatic hypotension with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
5
Deaths
28
Hospitalizations

How Dangerous Is Orthostatic hypotension From EMPAGLIFLOZIN?

Of the 46 reports, 5 (10.9%) resulted in death, 28 (60.9%) required hospitalization, and 2 (4.3%) were considered life-threatening.

Is Orthostatic hypotension Listed in the Official Label?

Yes, Orthostatic hypotension is listed as a known adverse reaction in the official FDA drug label for EMPAGLIFLOZIN.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Orthostatic hypotension?

FUROSEMIDE (1,442) AMLODIPINE (1,379) OXAZEPAM (714) DILTIAZEM (678) NITROGLYCERIN (673) LEVOTHYROXINE (671) OMEPRAZOLE (664) AMITRIPTYLINE (647) MORPHINE (646) ROSUVASTATIN (641)

Which EMPAGLIFLOZIN Alternatives Have Lower Orthostatic hypotension Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Orthostatic hypotension Reports All Drugs Causing Orthostatic hypotension EMPAGLIFLOZIN Demographics